Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RCN1P1, or reticulocalbin 1 pseudogene 1, is a non-functional, non-protein-coding DNA segment in the human genome related by sequence to the *Reticulocalbin 1* gene[4]. As a pseudogene, it does not produce a biologically active protein and is not considered a molecular drug target. Most relevant literature and biomedical interest is tied to the parent gene/protein, Reticulocalbin 1 (RCN1), which is a calcium-binding protein in the endoplasmic reticulum associated with protein folding and has emerging roles as a biomarker or possible therapeutic target in clear cell renal cell carcinoma[2][4]. If you are seeking information relevant to molecular targets for drug discovery or therapeutic development, the appropriate entry is "Reticulocalbin 1" (RCN1), not its pseudogene RCN1P1. Pseudogenes like RCN1P1 are generally not suitable for such roles since they do not produce functional proteins[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on reticulocalbin 1 pseudogene 1 (RCN1P1).